Related Experiment Video
Updated: Feb 8, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
Arsenic-induced apoptosis in the p53-proficient and p53-deficient cells through differential modulation of NFkB
1Department of Environmental Health Science, College of Public Health, University of Georgia, 150 Green Street, Athens, GA 30602, USA. Fax: 706.542.7472; ReproTox Biotech LLC, 111 Riverbend Drive, Athens, Georgia, United States.
Abstract:
Arsenic is a well-known environmental carcinogen and an effective chemotherapeutic agent. The underlying mechanism of this dual-effect, however, is not fully understood. In this study, we applied mouse p53+/+ and p53-/- cells to examine the NFκB pathway and proinflammatory cytokines after arsenic treatment. Arsenic reduced cell viability and increased more apoptosis in the p53-/- cells as compared to p53+/+ cells, which was correlated with activation of SAPK/JNK, p38 MAPK, and AKT pathways. A transcriptional regulatory network analysis revealed that arsenic activated transcription regulatory elements E2F, Egr1, Trp53, Stat6, Bcl6, Creb2 and ATF4 in the p53+/+ cells, while in the p53-/- cells, arsenic treatment altered transcription factors NFκB, Pparg, Creb2, ATF4, and Egr1. We observed dynamic changes in phosphorylated NFκB p65 (p-NFκB p65) and phosphorylated IKKαβ (p-IKKαβ) in both genotypes from 4 h to 24 h after treatment, significant decreases of p-NFκB p65 and p-IKKαβ in the p53-/- cells, whereas increases of p-NFκB p65 and p-IKKαβ were observed in the p53+/+ cells. Our study confirmed the differential modulation of NFκB pathway by arsenic in the p53+/+ or p53-/- cells and this observation of the differential mechanism of cell death between the p53+/+ and p53-/- cells might be linked to the unique ability of arsenic to act as both a carcinogen and a chemotherapeutic agent.
Insights
Arsenic exhibits dual effects as a carcinogen and chemotherapeutic agent. Its impact on the NF-kappaB pathway and cell death differs between p53+/+ and p53-/- cells, revealing distinct mechanisms.
Area of Science:
- Toxicology
- Molecular Biology
- Cancer Research
Background:
- Arsenic is recognized as both an environmental carcinogen and a chemotherapeutic agent.
- The precise mechanisms underlying arsenic's dual role remain incompletely understood.
- Investigating cellular responses to arsenic, particularly concerning the p53 tumor suppressor, is crucial.
Purpose of the Study:
- To investigate the differential effects of arsenic on the NF-kappaB pathway and proinflammatory cytokines in mouse cells with and without p53.
- To elucidate the molecular mechanisms contributing to arsenic's dual carcinogenic and chemotherapeutic properties.
- To compare cell viability, apoptosis, and key signaling pathway activation in response to arsenic exposure.
Main Methods:
- Utilized mouse p53+/+ and p53-/- cells for comparative analysis.
- Assessed cell viability and apoptosis following arsenic treatment.
- Analyzed the activation of SAPK/JNK, p38 MAPK, AKT, and NF-kappaB pathways.
- Performed transcriptional regulatory network analysis to identify altered transcription factors.
Main Results:
- Arsenic reduced cell viability and increased apoptosis in p53-/- cells compared to p53+/+ cells.
- Activation of SAPK/JNK, p38 MAPK, and AKT pathways was observed, particularly in p53-/- cells.
- Differential modulation of the NF-kappaB pathway was confirmed, with decreased p-NFκB p65 and p-IKKαβ in p53-/- cells and increases in p53+/+ cells.
- Arsenic altered distinct sets of transcription factors depending on p53 status.
Conclusions:
- Arsenic differentially modulates the NF-kappaB pathway in a p53-dependent manner.
- The distinct mechanisms of cell death observed in p53+/+ and p53-/- cells may explain arsenic's dual role as a carcinogen and chemotherapeutic agent.
- Understanding these differential responses is key to harnessing arsenic's therapeutic potential while mitigating its carcinogenic risks.
Related Concept Videos
Negative Regulator Molecules
Apoptosis
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Induced Pluripotent Stem Cells
iPS Cell Differentiation

